Catalyst Funds Management’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-21,824
Closed -$52.8K 746
2026
Q1
$52.8K Buy
+21,824
New +$59.5K 0.01% 538
2025
Q2
Sell
-11,238
Closed -$30.3K 547
2025
Q1
$30.3K Buy
+11,238
New +$42.2K 0.01% 429
2024
Q4
Sell
-4,800
Closed -$11.4K 722
2024
Q3
$11.4K Hold
4,800
﹤0.01% 1167
2024
Q2
$9.36K Buy
+4,800
New +$16.3K ﹤0.01% 944

Other funds holding GNLX

Catalyst Funds Management's GNLX Position: Q2 2026 in Review

Catalyst Funds Management sold out of Genelux (GNLX) in Q2 2026, closing a stake of 21,824 shares — an estimated $52.8K sold.

Catalyst Funds Management first reported a position in GNLX in Q2 2024 and held it in 4 quarters. The position peaked at $52.8K in Q1 2026. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Catalyst Funds Management reported no remaining Genelux position as of Q2 2026 after selling out during the quarter.
  • Catalyst Funds Management sold 21,824 Genelux shares in Q2 2026, an estimated $52.8K.
  • Catalyst Funds Management first reported a position in Genelux in Q2 2024 and held it in 4 quarters.
  • Catalyst Funds Management's Genelux position peaked at $52.8K in Q1 2026.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.